Regeneron, Sanofi Say Eczema Drug Met Targets in Late-Stage Studies

Regeneron Pharmaceuticals and Sanofi said their experimental drug for a debilitating skin condition called atopic dermatitis met all of its major treatment targets in two late-stage studies.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news